Cite
Borner T, Geisler CE, Fortin SM, et al. GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models. Diabetes. 2021;70(11):2545-2553doi: 10.2337/db21-0459.
Borner, T., Geisler, C. E., Fortin, S. M., Cosgrove, R., Alsina-Fernandez, J., Dogra, M., Doebley, S., Sanchez-Navarro, M. J., Leon, R. M., Gaisinsky, J., White, A., Bamezai, A., Ghidewon, M. Y., Grill, H. J., Crist, R. C., Reiner, B. C., Ai, M., Samms, R. J., De Jonghe, B. C., & Hayes, M. R. (2021). GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models. Diabetes, 70(11), 2545-2553. https://doi.org/10.2337/db21-0459
Borner, Tito, et al. "GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models." Diabetes vol. 70,11 (2021): 2545-2553. doi: https://doi.org/10.2337/db21-0459
Borner T, Geisler CE, Fortin SM, Cosgrove R, Alsina-Fernandez J, Dogra M, Doebley S, Sanchez-Navarro MJ, Leon RM, Gaisinsky J, White A, Bamezai A, Ghidewon MY, Grill HJ, Crist RC, Reiner BC, Ai M, Samms RJ, De Jonghe BC, Hayes MR. GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models. Diabetes. 2021 Nov;70(11):2545-2553. doi: 10.2337/db21-0459. Epub 2021 Aug 11. PMID: 34380697; PMCID: PMC8564411.
Copy
Download .nbib